Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Long-term safety in psoriasis and psoriatic arthritis patients treated with apremilast: pooled analysis for up to 156 weeks in the ESTEEM and PALACE 1-3 phase 3 trials. Academia Española de Dermatología y Venereología (AEDV) Madrid, May 2017.
Academia Española de Dermatología y Venereología (AEDV) (2017)
  • J Crowley
  • J Wollenhaupt
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Link
Disciplines
Publication Date
May, 2017
Citation Information
J Crowley, J Wollenhaupt, Philip Mease and et.al.. "Long-term safety in psoriasis and psoriatic arthritis patients treated with apremilast: pooled analysis for up to 156 weeks in the ESTEEM and PALACE 1-3 phase 3 trials. Academia Española de Dermatología y Venereología (AEDV) Madrid, May 2017." Academia Española de Dermatología y Venereología (AEDV) (2017)
Available at: http://works.bepress.com/philip-mease/301/